Efficacy of abatacept or infliximab treatment in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a 1-year double-blind, randomized, placebo-controlled trial

被引：0
|
作者：
Bessette, L. [1 ]
Homik, J. [2 ]
Dougados, M. [3 ]
Keiserman, M. [4 ]
Codding, C. [5 ]
Songcharoen, S.
Berman, A. [6 ]
Nayiager, S. [7 ]
Saldate, C. [8 ]
Aranda, R. [9 ]
Becker, J. [9 ]
Li, T. [9 ]
Lin, C. [10 ]
Cornet, P. L. N. [11 ]
Schiff, M. [12 ]
机构：
[1] Univ Quebec, Ctr Hosp, Ste Foy, PQ G1V 2M3, Canada
[2] Univ Alberta, Edmonton, AB, Canada
[3] Hop Cochin, F-75674 Paris, France
[4] Pontificia Univ Catolica, Sch Med, Porto Alegre, RS, Brazil
[5] Hlth Res Oklahoma, Oklahoma City, OK USA
[6] Ctr Med Privade Reumatol, San Miguel De Tucuman, Argentina
[7] St Augustines Med Ctr, Durban, South Africa
[8] Ctr Investigac Noroeste, Tijuana, Mexico
[9] Bristol Myers Squibb Co, Princeton, NJ USA
[10] Bristol Myers Squibb Co, Hopewell Jct, NY USA
[11] Bristol Myers Squibb Co, Shanghai, Peoples R China
[12] Denver Arthritis Clin, Denver, CO USA
来源：
JOURNAL OF RHEUMATOLOGY | 2008年 / 35卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1178 / 1179
页数：2
相关论文
共 50 条
  • [1] Efficacy of abatacept or infliximab treatment in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a 1-year double-blind, randomized, placebo-controlled trial
    Dougados, M.
    Keiserman, M.
    Codding, C.
    Songcharoen, S.
    Berman, A.
    Nayiager, S.
    Saldate, C.
    Aranda, R.
    Becker, J.
    Li, T.
    Lin, C.
    Cornet, R. L. N.
    Schiff, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 88 - 88
  • [2] The efficacy and safety of abatacept or infliximab in ra patients with an inadequate response to MTX: Results from a 1-year double-blind, randomized, placebo-controlled trial
    Bessette, Louis
    Schiff, Michael
    Kieserman, Mauro
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (07) : 1627 - 1627
  • [3] The efficacy and safety of abatacept or infliximab in RA patients with an inadequate response to MTX: Results from a 1-year double-blind, randomized, placebo-controlled trial.
    Schiff, M.
    Keiserman, M.
    Codding, C.
    Songcharoen, S.
    Berman, A.
    Nayiager, S.
    Saldate, S.
    Aranda, R.
    Becker, J-C
    Lin, C.
    Cornet, L. N.
    Dougados, M.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4117 - 4118
  • [4] Efficacy of abatacept or infliximab in RA patients with an inadequate response to MTX: Results from a 1-year double-blind randomized clinical trial
    van Vollenhoven, Ronald
    Dougados, M.
    Keiserman, M.
    Codding, C.
    Songcharoen, S.
    Berman, A.
    Nayiageir, S.
    Saldatc, C.
    Aranda, R.
    Becker, J.
    Li, T.
    Lin, C.
    Comet, P. L. N.
    Schiff, M.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 : 51 - 51
  • [5] Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis - A double-blind, randomized, placebo-controlled trial
    van Dongen, Henrike
    van Aken, Jill
    Lard, Leroy R.
    Visser, Karen
    Ronday, H. Karel
    Hulsmans, Harry M. J.
    Speyer, Irene
    Westedt, Marie-Louise
    Peeters, Andre J.
    Allaart, Cornelia F.
    Toes, Rene E. M.
    Breedveld, Ferdinand C.
    Huizinga, Tom W. J.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (05): : 1424 - 1432
  • [6] Diacerein for the treatment of rheumatoid arthritis in patients with inadequate response to methotrexate: a pilot randomized, double-blind, placebo-controlled add-on trial
    Louthrenoo, Worawit
    Nilganuwong, Surasak
    Nanagara, Ratanavadee
    Siripaitoon, Boonjing
    Basset, Sabine Collaud
    CLINICAL RHEUMATOLOGY, 2019, 38 (09) : 2461 - 2471
  • [7] Effectiveness of Abatacept or infliximab in patients with rheumatoid arthritis and insufficient response to methotrexate: Results of a randomised, double-blind placebo-controlled study over one year
    Altmann, M.
    Dougados, M.
    Keiserman, M.
    Aranda, R.
    Becker, J.
    Li, T.
    Schiff, M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 78 - 78
  • [8] Diacerein for the treatment of rheumatoid arthritis in patients with inadequate response to methotrexate: a pilot randomized, double-blind, placebo-controlled add-on trial
    Worawit Louthrenoo
    Surasak Nilganuwong
    Ratanavadee Nanagara
    Boonjing Siripaitoon
    Sabine Collaud Basset
    Clinical Rheumatology, 2019, 38 : 2461 - 2471
  • [9] Safety of abatacept or infliximab in RA patients with an inadequate response to MTX: Results from a 1-year double-blind randomized clinical trial
    Ronald, Van Vollenhoven
    Schiff, M.
    Keiserman, M.
    Codding, C.
    Songcharoen, S.
    Berman, A.
    Nayiager, S.
    Saldate, S.
    Aranda, R.
    Becker, J.-C.
    Lin, C.
    Cornet, P. L. N.
    Dougados, M.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 : 52 - 52
  • [10] EFFICACY AND SAFETY OF LEVILIMAB IN COMBINATION WITH METHOTREXATE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: 1-YEAR RESULTS OF PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL
    Mazurov, V.
    Korolev, M.
    Pristrom, A.
    Kundzer, A.
    Soroka, N.
    Kastanayan, A.
    Povarova, T.
    Plaksina, T.
    Antipova, O.
    Kretchikova, D.
    Smakotina, S.
    Tciupa, O.
    Puntus, E.
    Raskina, T.
    Shilova, L.
    Kropotina, T.
    Nesmeyanova, O.
    Popova, T.
    Vinogradova, I.
    Linkova, I.
    Plotnikova, A.
    Pukhtinskaia, P.
    Zinkina-Orikhan, A.
    Eremeeva, A.
    Lutckii, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 596 - 596
12345